Biocryst Pharmaceuticals (BO1.F) Q4 2024 Earnings

4NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.29
-0.21
-0.13
-0.05

Details

Expected EPS
-0.06251920000000001
Actual EPS
-0.06435800000000001
Surprise EPS
-0
Surprise Percent
+2.94%

Description

Biocryst Pharmaceuticals (BO1.F) has reported earnings of -0.06435800000000001 per share for Q4 2024.

0 Comments

Share your thoughts